layout.fixed.naaccr.doc.naaccr22.rxSummHormone.html Maven / Gradle / Ivy

Go to download

Show more of this group Show more artifacts with this name
Show all versions of layout Show documentation

Framework that allows defining file formats (layouts) and use them to read and write data files.

There is a newer version: 6.0


    
        Item #
        Length
        Source of Standard
        Year Implemented
        Version Implemented
        Year Retired
        Version Retired
    
    
        1400
        2
        SEER/CoC
        
        
        
        
    



NAACCR XML: Tumor.rxSummHormone


Alternate Names

   Hormone Therapy (SEER/CoC)

   Endocrine (Hormone/Steroid) Therapy (pre-96 SEER)


Description
Records whether systemic hormonal agents were administered as first-course treatment at any facility, or the reason they were not given. Hormone therapy consists of a group of drugs that may affect the long-term control of a cancer’s growth. It is not usually used as a curative measure.
Rationale
Systemic therapy may involve the administration of one or a combination of agents. This data item allows for the evaluation of the administration of hormonal agents as part of the first course of therapy.
Codes (Refer to the most recent version of STORE and the SEER Program Code Manual for additional instructions.) 

    
        
            00
            None, hormone therapy was not part of the planned first course of therapy.
        
        
            01
            Hormone therapy administered as first course therapy.
        
        
            82
            Hormone therapy was not recommended/administered because it was contraindicated due to patient risk factors (i.e., comorbid conditions, advanced age).
        
        
            85
            Hormone therapy was not administered because the patient died prior to planned or recommended therapy.
        
        
            86
            Hormone therapy was not administered. It was recommended by the patient's physician, but was not administered as part of first-course therapy. No reason was stated in the patient record.
        
        
            87
            Hormone therapy was not administered. It was recommended by the patient's physician, but this treatment was refused by the patient, the patient's family member, or the patient's guardian. The refusal was noted in the patient record.
        
        
            88
            Hormone therapy was recommended, but it is unknown if it was administered.
        
        
            99
            It is unknown whether a hormonal agent(s) was recommended or administered because it is not stated in the patient record. Death certificate-only cases.
        
    


    Note: For tumors diagnosed on or after January 1, 2003, information on endocrine surgery and/or endocrine radiation should be coded in the new field, RX Summ--Transplnt/Endocr [3250]. The CoC standards for hospitals do not allow use of codes 02-03 in tumors diagnosed on or after January 1, 2003.

00	None, hormone therapy was not part of the planned first course of therapy.
01	Hormone therapy administered as first course therapy.
82	Hormone therapy was not recommended/administered because it was contraindicated due to patient risk factors (i.e., comorbid conditions, advanced age).
85	Hormone therapy was not administered because the patient died prior to planned or recommended therapy.
86	Hormone therapy was not administered. It was recommended by the patient's physician, but was not administered as part of first-course therapy. No reason was stated in the patient record.
87	Hormone therapy was not administered. It was recommended by the patient's physician, but this treatment was refused by the patient, the patient's family member, or the patient's guardian. The refusal was noted in the patient record.
88	Hormone therapy was recommended, but it is unknown if it was administered.
99	It is unknown whether a hormonal agent(s) was recommended or administered because it is not stated in the patient record. Death certificate-only cases.